The outbreak of "mad cow" disease (BSE) in Britain had been connected epidemiologically to feeding of concentrates containing meat-bone meal (MBM) to dairy calves (Wilesmith et al.,1988, 1991,1992a, 1992b) . Beef cattle breeding herds (which generally do not have their rations supplemented with protein concentrates) have had a much lower BSE incidence in the UK, supporting this feed additive theory of BSE.
Since the practice of feeding animal protein is not new, the disease outbreak in the mid 1980's cannot be explained solely by the hypothesis of a disease agent in MBM. However, it has been hypothesized that the cessation of hydrocarbon solvent extraction of fat from MBM in the early 1980's at most rendering plants in England could have allowed an infective scrapie-like agent to pass into dairy feed (Wilesmith et al., 1991).This may not be the only possible explanation, as it was pointed out by Rhodes (1997) that another change in the cow's diet also could explain the epidemic, which was initiated by the higher prices for imported soy and fish meal in the early 1980's. This forced farmers to shift to greater use of the cheaper MBM. There is also reason to believe that the infective prion, reputed to be the cause of BSE, is sufficiently hardy that changes in the rendering plant processing of MBM may not have greatly affected infectivity. Taylor (1998) stated that "most of the rendering procedures used to manufacture meat and bone meal (MBM) throughout the European Union have been found to be incapable of inactivating BSE and scrapie agents". Even autoclaving at 132-138 C is not completely effective (Taylor, 1998). This observation, along with the fact that other countries have fed similarly processed MBM to dairy animals without causing an epidemic of BSE, suggests that an environmental or nutritional factor in certain regions of the UK is a predisposing or causative factor in the disease.
It is curious that the geographic occurrence of "mad cow" disease (number of cases per 1000 head) is not evenly or randomly distributed in the UK, but has tended throughout the epidemic to be highest in the southern and eastern counties (Wilesmith et al., 1992a). Several counties in this region are known to have widespread copper defiencies in soils and crops (Thornton and Webb, 1980). These crop deficiencies could lead to copper deficiency in ruminants, a fairly well-recognized disease with specific symptoms, in those regions without copper supplements in rations. BSE has tended to have higher occurrence in particular herds, even though there is no definitive evidence that the disease can be transmitted animal-to-animal.Since consumption of MBM presumeably varies from animal to animal, the impact on some animals could be much greater than on others.
One impact of a high-MBM diet could be to induce Cu
deficiency, as feeds rich in protein , particularly soluble protein,
decrease the efficiency of Cu absorption by ruminants (Rehbinder and
Petersson, 1994 ; McDowell, 1985)
The use of animal protein, which increases nitrogen in the
feed, could lead to a deficiency of essential fatty acids in the cell
membranes, reducing membrane integrity , and making the animal more
susceptible to encephalomalacia (Crawford et al., 1991). The fairly
recent increased use of canola seed cake in animal rations in the UK
could also contribute to this nutritional imbalance, as canola has a
high sulfur content and can accumulate certain toxic metals from soils
in the seed
Based on the number of references that can be found where Cu deficiency has been diagnosed in numerous ruminant species in the wild, as well as captive or in a farming environment, Cu deficiency appears to be common. It has been observed in cattle, moose, red deer, Sika deer, elk , muskoxen and goats (Mackintosh,1998 ; Stafford, 1997; Blakley et al.,1998; Arnhold et al., 1998; Gogan et al., 1989), particularly in cases where wild animals have been captive or confined. Wapiti (elk) may be particularly susceptible to Cu deficiency, and the disease is reported frequently in red deer on farms (Blakley et al., 1992). Confining wild ruminants on farms appears to increase the risk of certain diseases, including copper and other trace element deficiencies (Mackintosh, 1998). Wild ruminants may be able to compensate for soil deficiency of particular micronutrients by obtaining a more varied diet than confined ruminants restricted largely to grass forage (Stafford, 1997). Interestingly, wild ruminants appear to be better adapted to low-Cu diets than most domesticated ruminants, as the necessary level of Cu in the liver tissue of domesticated sheep and cows ( 35 mg/kg dw) is higher than that for deer (10-20 mg/kg) (Arnhold et al., 1998). Domestic goats require even less Cu (8 mg/kg in liver), and it is interesting that the Cu level in the cerebrum is a more reliable indicator of Cu deficiency in goats than that in the liver (Arnhold et al., 1998). Cerebrum Cu concentrations in goats are generally less than 10 mg/kg (dw), levels considered to be marginal or low in sheep and cattle.
Neurological Symptoms in Copper Deficiency and TSE's
In sheep, copper deficiency has been recognized
in the UK and elsewhere for a long time as the disease referred to as
swayback. Neurological degeneration from swayback has generally been
described as demyelination, but more recent investigations of the
neuropathology note vacuolation of the white matter, neuronal necrosis,
gliosis (Mohammed et al., 1995). Demyelination has been observed in
deer with copper deficiency (Geisel et al., 1997; Yoshikawa et al.,
1996). However, Yoshikawa et al.(1996) described the neuropathology as
"spongy vacuolation and myelin deficiency in the white matter of the
spinal cord and brain stem" .
Chronic wasting disease in wild moose has become relatively common in Southern Sweden, and there is evidence that it is caused by Cu deficiency possibly induced by increased molybdenum in the forage (Frank, 1998). Neurological pathology associated with this disease is described as " abiotrophy of the cerebellum characterized by a marked thinning and decreased cellularity of the granular layer and a severe loss of Purkinje cells, leaving empty 'baskets' as reminiscences". (Rehbinder et al.,1991; Rehbinder and Petersson, 1994).
Some researchers believe that neuronal degeneration in a number of diseases could have Cu deficiency as an etiological factor (Hartmann and Evenson, 1992). Menkes' kinky hair disease in infants and young children is a rare X-chromosome-linked genetic disorder of copper transport which appears to result from copper being trapped in certain tissues, especially the kidneys, by abnormal metabolism of metallothionein (Nooijen et al., 1981; Hart, 1983). This leads to copper deficiency, particularly in the brain, causing irreversible damage. The neurological degeneration in Menkes' disease is pathologically similar to that in Cu deficiency of sheep (swayback) (Tan and Urich, 1983), evidence that brain damage in Menkes' is substantially due to Cu deficiency. Neurological damage progresses in infants in spite of copper therapy (Johnsen et al., 1991), with copper accumulating in certain tissues incliuding the kidney, and remaining low in the brain and liver.
Some descriptions of the pathology of central nervous system degeneration from Menkes' disease include :
"...neuronal destruction was widespread in the cerebral gray matter and in the cerebellum, and there was associated gliosis. The changes in the cerebellum were particularly severe , with neuronal loss in the internal granular cell layer. Many Purkinje cells were lost...." (Moon et al., 1987)
"... prominent vascular, cerebral and cerebellar degeneration." (Morgello et al., 1988)
"....marked neuronal loss and gliosis in most areas of the cerebral and cerebellar cortices, midbrain , pons and medulla. The spinal cord showed severe demyelination " (Uno and Arya, 1987)
" The cerebellum showed the most striking abnormalities : severe lack of internal granule cells. Purkinje cells with weeping willow pattern..." (Robain et al., 1988)
These descriptions bear a marked similarity to those noted above for Cu deficient ruminants, and, as will be discussed later, have considerable similarity to the neuropathology of the "transmissible spongiform diseases" of animals and humans.
Spongiform change itself does not appear to be particularly unique to prion diseases. For example, lead poisoning in dogs produced a neuropathology described as "cerebrocortical lesions comprising spongiosis, vascular hypertrophy and gliosis", as well as "spongiform changes" in the cerebellum with "spongiosis of the Purkinje cell layer and vacuolation of Purkinje cells" (Hamir et al., 1984). In cattle, Christian and Tryphonas (1971) observed that chronic lead poisoning produced "astrocytic swelling and development of focal status spongiosis" and "neuronal necrosis", and remarked that lead encephalopathy may be difficult to distinguish from polioencephalomalacia (PEM), especially in the acute stages. PEM was initially thought to be a thiamin deficiency, as the administration of thiamin often alleviated symptoms. However, recent evidence suggests that thiamin has the ability to counteract lead toxicosis (Gould, 1998).
Demyelination has been usually associated with Cu deficiency, for example, swayback disease in lambs. However, degeneration of myelin sheaths has also been reported in spongiform CNS disease in goats and mule deer (Obermaier et al., 1995; Guiroy et al., 1993) , as well as in scrapie and Creutzfeldt-Jacob disease (Walis et al., 1997; El Hachimi et al., 1998). Copper deficiency is also associated with neuronal degeneration and spongiform pathology, so again, we see evidence that the neuropathology of these presumed different diseases has similarity that may confuse diagnosis. Treatment of experimental animals with Cu-chelating compounds produces neural abnormalities including "spongiform changes in white matter" and "reduced myelin development" (Tanaka et al., 1993).
Given this unclear distinction in pathological symptoms of TSE's and other CNS diseases, one must question some of the conclusions that have been reached on the occurrence of TSE's in animals where disease transmission studies have not been done. Specifically, the neurological damage caused by Cu deficiency, and possibly exposure to neurotoxins such as lead, may not be easily distinguished from the damage from TSE's.
These unexplained facts would seem to suggest the existence of (as yet undiscovered) location-dependent environmental factors which may not actually cause TSE diseases, but predispose individuals to infection. For example, Agrimi and DiGuardo (1993) have proposed that the blood-brain barrier may be compromised in susceptible hosts, resulting in localization of metals such as lead in brain tissue, as has been shown in Alzheimer's disease. Heavy metals and/or Cu deficiency may damage the integrity of the blood-brain-barrier, increasing the chance of disease transmission.
Contaminant metal binding to PrP in MBM may convert the PrP to the infective form; that is, a form that is not readily digested by proteases in the digestive tract, and that is able to cross membrane barriers into the blood stream and finally to the central nervous system (CNS). A recent study has shown that Cu ions can convert PrP to the infective disease form (McKenzie et al.,1998). Warren (1974) noted a long time ago that there was at least circumstantial evidence for a role of environmental lead in numerous CNS diseases. He pointed to evidence that suggested divalent metal cations alter membrane permeability, and that "heavy metal cations stimulate degradation of the phospholipids in membranes". Since copper deficiency leads to developmental abnormalities in the cerebellum and demyelination of the spinal cord in ruminants (Rehbinder and Petersson, 1994), and recently has been shown to bind with high specificity to PrP, one should also consider that copper deficiency or excess toxic metals might predispose animals to infection with TSE diseases.
Generally, wild deer and elk have not shown this disease at high levels except in one region of Colorado and Wyoming. Outward symptoms in these animals are loss of body condition (wasting), behavioral changes, excessive drinking and urinating, salivation, incoordination, and tremors. Recent observations seem to put in question the belief that "chronic wasting disease" (CWD) of these wild animals is a prion disease at all. Sika deer on farms showed enzootic ataxia, with neuropathological lesions reported as spongy vacuolation in white matter of spinal cord and brain stem. The disease was attributed to copper deficiency (Yoshikawa et al., 1996) . Moose in Sweden showed ataxia, wasting, and excessive salivation, with neuropathology reported as cerebellum abnormalities characterized by a marked thinning and decreased cellularity of the granular layer and a severe loss of Purkinje cells. The disease was again attributed to copper deficiency (Frank, 1998)
There are commonly reported incidences of Cu deficiency, diagnosed on the basis of very low blood and liver copper, in many regions of the world. These deficiencies often occur when wild deer, elk and other ruminants are confined on farms or ranches, and it is notable that CWD was observed in confined populations of deer and elk in Western North America for decades prior to the "outbreak" in wild populations of Colorado and Wyoming. There is evidence that confinement prevents animals from browsing for more Cu-rich plant material.
The occurrence of CWD in deer in the Western US, and no report (as yet) of the disease in the East, is consistent with the fact that soils of the West, particularly in the Colorado-Wyoming region and the arid Southwest, are prone to produce forages with high Mo content relative to Cu, potentially leading to Cu deficiency. Alfalfa hay is often fed to deer and elk on farms.Are we able to distinguish a prion disease from Cu deficiency solely on the basis of observations of symptoms in the field, or even cursory examination of brain tissue?
Even if the prion-only theory of BSE proves to be substantially correct, copper and other trace metals may have a key role in controlling infectivity of this molecule. It now appears that the normal prion protein (PrP) of nerve cells in the brain could have a key role in the critical functions of copper in the brain. Recent work shows that copper rapidly and reversibly stimulates endocytosis of PrP from the cell surface (Pauly and Harris, 1998). This could mean that the normal prion acts as Cu sink, since it strongly chelates the metal, or functions as a carrier to deliver Cu into the brain cells. McKenzie et al. (1998) have shown that Cu restores infectivity of scrapie prion (PrPSc), increasing protease resistance after the scrapie prion had been denatured by guanidine.
A number of compounds, including tetrapyrroles (e.g., porphyrin), polyanionic sulfated glycans (e.g., dextran sulfate, pentosan sulfate), and Congo Red, have been shown to interfere with the development of scrapie in mice (Ladogana et al., 1992) and inhibit the formation of protease-resistant PrP in cells (Caughey et al, 1994). There were several studies done in the 1970's that showed a scrapie-like disease to be generated in laboratory animals by feeding them cuprizone, a Cu-selective chelating agent. Treatment of mice with triethylene tetramine dihydrochloride, a Cu-chelating compound, produces neural abnormalities their offspring, including "spongiform changes in white matter" and "reduced myelin development" (Tanaka et al., 1993). This suggests that the removal of Cu from neural cell PrP by soluble chelators could lead to the same pathological symptoms in the brain as caused by TSE disease. In effect, treatment of animals with cuprizone would induce severe Cu-deficiency and the concomitant neuronal degeneration.
Arnhold W, Anke M, Glei M, Rideout B, Stalis I, Lowenstine L, Edwards M, Schuppel KF, Eulenberger K, Notzold G. 1998. Trace Elements and Electrolytes. 15, 65-69.
Blakley BR, Haigh JC, McCarthy WD. 1992. Canadian Veterinary Journal. 33, 549-550.
Blakley BR, Tedesco SC, Flood PF.1998. Canadian Veterinary Journal. 39, 293-295.
Caughey B et al. 1994. J Virol. 68, 2135-2141.
Christian RG, Tryphonas L. 1971. Am J Vet Res, 32, 203-216.
Crawford MA, Budowski P, Drury P, Ghebremeskel K, Harbige L. 1991. Nutr Health, 7, 61-68.
Ebringer A, Pirt J, Wison C, Cunningham P, Thorpe C, Ettelaie C. 1997 Environmental Health Perspectives, 105, 1172-1174.
El Hachimi KH, Chaunu MP, Brown P, Foncin JF. 1998. Experimental Neurology 154, 23-30.
Frank A. 1998. Science of the Total Environment, 209, 17-26.
Geisel O, Betzl E, Dahme E, Schmahl W, Hermanns W. 1997. Tierarztl Prax Ausg G Grosstiere Nutztiere , 25, 598-604.
Gogan PJP, Jessup DA, Akeson M. 1989. Journal of Range Management, 42, 233-238.
Gould DH. 1998. J Animal Sci, 76, 309-314
. Guiroy DC, Williams ES, Liberski PP, Wakayama I, Gajdusek DC. 1993. Acta Neuropathologica, 85, 437-444.
Hamir AN, Sullivan ND, Handson PD. 1984. J Comp Pathol , 94, 215-231.
Hart DB. 1983. J Am Acad Dermatol 9, 145-152.
Hartmann HA, Evenson MA. 1992. Medical Hypotheses, 38, 75-85.
Johnsen DE, Coleman L, Poe L. 1991. Neuroradiology, 33, 181-182.
Kirkwood JK, Cunningham AA, Wells GAH, Wilesmith JW, Barnett JEF. 1993. Veterinary Record, 133, 360-364.
Ladogana A et al. 1992. J Gen Virol. 73, 661-665.
Mackintosh, CG.1998. Acta Veterinaria Hungarica, 46, 381-394.
McDowell LR. 1985. pp. 237-257. In "Nutrition of Grazing Ruminants in Warm Climates", LR McDowell (ed.) Academic Press, NY.
McKenzie et al. 1998, J.Biol.Chem., 273, 25545-47.
Milhaud GE and S Mehennaoui. 1988.Vet Human Toxicol, 30, 513-517.
Mohammed A, Adogwa A, Youssef FG. 1995. Molecular and Chemical Neuropathology, 24, 257-261.
Moon HR, Chi JG, Yeon KM, Suh YL, Sung RH, Kim BI, Rhi JL, Kim SH. 1987. J Korean Med Sci, 2, 75-83.
Morgello S, Peterson HD, Kahn LJ , Laufer H. 1988. Dev Med Child Neurol, 30, 812-816.
Nooijen JL, DeGroot CJ, Van den Hamer CJ, Monnens LA, Willemse J, Niermeijer MF. 1981. Pediatric Research, 15, 284-289.
Obermaier G, Kretzschmar HA, Hafner A, Heubeck D, Dahme E. 1995. Journal of Comparative Pathology, 113, 357-372.
Pauly PC, Harris DA. 1998. J Biol Chem, 273, 33107-33110.
Rehbinder C, Gimeno E, Belak K, Belak S, Steen M, Rivera E, Nikkila T. 1991. the Veterinary Record, 129, 552-554.
Rehbinder C, Petersson L. 1994. Acta Vet Scand 35, 107-110.
Rhodes R. 1997. Deadly Feasts. Touchstone, NY.
Robain O, Aubourg P, Routon MC, Dulac O, Ponsot G. 1988. Clin Neuropathol, 7, 47-52.
Stafford, KJ. 1997. New Zealand Journal of Zoology, 24, 267-271.
Suttle NF, BJ Alloway and I Thornton. 1975. J Agric Sci (Cambridge) 84, 249-254.
Tan N, Urich H. 1983. J Neurol Sci, 62, 95-113.
Tanaka H, Inomata K, Arima M. 1993. Journal of Nutritional Science and Vitaminology, 39, 177-188.
Taylor DM. 1998.Journal of Food Safety 18, 265-274.
Thornton and Abrahams 1983, the Science of the Total Environment, 28, 287-294.
Thornton I and JS Webb. 1980.pp. 381-439. In BE Davies (ed.) Applied Soil Trace Elements. Wiley, NY.
Uno H, Arya S. 1987, Am J Med Genet Suppl, 3, 367-377.
Warren HV. J. Biosoc. Sci., 1974, 6, 223-238.
Walis A, Liberski PP, Brown P, Gajdusek DC. 1997. Folia Neuropathologica 35, 255-258.
Wilesmith JW, Ryan JBM, Atkinson MJ. 1991. Veterinary Record, 128, 199-203.
Wilesmith JW, Ryan JBM, Hueston WD, Hoinville LJ. 1992a. Veterinary Record, 130,90-94.
Wilesmith JW, Ryan JBM, Hueston WD. 1992b.Research in Veterinary Science, 52, 325-331.
Wilesmith JW, Wells GAH, Cranwell MP, Ryan JBM. 1988. Veterinary Record, 123, 638-644.
Yoshikawa H, Seo H, Oyamada T, Ogasawara T, Oyamada T, Yoshikawa T, Wei
XB, Wang SQ, Li YX. 1996. Journal of Veterinary Medical Science, 58,
849-854.